abstract |
The present invention relates to a composition comprising probiotic bacteria for the curative or preventive treatment of metabolic syndrome, enlarged liver, non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH) in a subject, and a pharmaceutical preparation or medical device or food supplement comprising said composition. |